China Biotech Services Holdings Limited

SEHK:8037 株式レポート

時価総額:HK$409.8m

China Biotech Services Holdings 将来の成長

Future 基準チェック /06

現在、 China Biotech Services Holdingsの成長と収益を予測するのに十分なアナリストの調査がありません。

主要情報

n/a

収益成長率

n/a

EPS成長率

Healthcare 収益成長22.1%
収益成長率n/a
将来の株主資本利益率n/a
アナリストカバレッジ

None

最終更新日n/a

今後の成長に関する最新情報

Recent updates

China Biotech Services Holdings Limited's (HKG:8037) 28% Share Price Plunge Could Signal Some Risk

Aug 12
China Biotech Services Holdings Limited's (HKG:8037) 28% Share Price Plunge Could Signal Some Risk

Some Shareholders Feeling Restless Over China Biotech Services Holdings Limited's (HKG:8037) P/S Ratio

Jun 26
Some Shareholders Feeling Restless Over China Biotech Services Holdings Limited's (HKG:8037) P/S Ratio

China Biotech Services Holdings Limited's (HKG:8037) Popularity With Investors Under Threat As Stock Sinks 31%

Mar 07
China Biotech Services Holdings Limited's (HKG:8037) Popularity With Investors Under Threat As Stock Sinks 31%

Earnings Not Telling The Story For China Biotech Services Holdings Limited (HKG:8037) After Shares Rise 46%

Jan 18
Earnings Not Telling The Story For China Biotech Services Holdings Limited (HKG:8037) After Shares Rise 46%

We Think China Biotech Services Holdings (HKG:8037) Might Have The DNA Of A Multi-Bagger

Jan 06
We Think China Biotech Services Holdings (HKG:8037) Might Have The DNA Of A Multi-Bagger

Does China Biotech Services Holdings (HKG:8037) Have A Healthy Balance Sheet?

Dec 09
Does China Biotech Services Holdings (HKG:8037) Have A Healthy Balance Sheet?

These 4 Measures Indicate That China Biotech Services Holdings (HKG:8037) Is Using Debt Safely

Aug 24
These 4 Measures Indicate That China Biotech Services Holdings (HKG:8037) Is Using Debt Safely

A Look At The Fair Value Of China Biotech Services Holdings Limited (HKG:8037)

Nov 05
A Look At The Fair Value Of China Biotech Services Holdings Limited (HKG:8037)

Is China Biotech Services Holdings (HKG:8037) A Risky Investment?

Oct 13
Is China Biotech Services Holdings (HKG:8037) A Risky Investment?

What China Biotech Services Holdings Limited's (HKG:8037) 35% Share Price Gain Is Not Telling You

Jun 28
What China Biotech Services Holdings Limited's (HKG:8037) 35% Share Price Gain Is Not Telling You

China Biotech Services Holdings (HKG:8037) Could Become A Multi-Bagger

Mar 16
China Biotech Services Holdings (HKG:8037) Could Become A Multi-Bagger

China Biotech Services Holdings (HKG:8037) Knows How To Allocate Capital Effectively

Dec 01
China Biotech Services Holdings (HKG:8037) Knows How To Allocate Capital Effectively

Under The Bonnet, China Biotech Services Holdings' (HKG:8037) Returns Look Impressive

Jul 26
Under The Bonnet, China Biotech Services Holdings' (HKG:8037) Returns Look Impressive

China Biotech Services Holdings' (HKG:8037) Robust Earnings Are Supported By Other Strong Factors

Apr 05
China Biotech Services Holdings' (HKG:8037) Robust Earnings Are Supported By Other Strong Factors

Investors Shouldn't Overlook China Biotech Services Holdings' (HKG:8037) Impressive Returns On Capital

Mar 23
Investors Shouldn't Overlook China Biotech Services Holdings' (HKG:8037) Impressive Returns On Capital

Did You Miss China Biotech Services Holdings' (HKG:8037) Whopping 825% Share Price Gain?

Feb 23
Did You Miss China Biotech Services Holdings' (HKG:8037) Whopping 825% Share Price Gain?

Chun-Shun Ko Just Bought 27% More Shares In China Biotech Services Holdings Limited (HKG:8037)

Jan 28
Chun-Shun Ko Just Bought 27% More Shares In China Biotech Services Holdings Limited (HKG:8037)

What Is The Ownership Structure Like For China Biotech Services Holdings Limited (HKG:8037)?

Jan 11
What Is The Ownership Structure Like For China Biotech Services Holdings Limited (HKG:8037)?

The Trend Of High Returns At China Biotech Services Holdings (HKG:8037) Has Us Very Interested

Dec 08
The Trend Of High Returns At China Biotech Services Holdings (HKG:8037) Has Us Very Interested

このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、China Biotech Services Holdings は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。

シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。

業績と収益の成長予測

SEHK:8037 - アナリストの将来予測と過去の財務データ ( )HKD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
6/30/202462-145-419-211N/A
3/31/202498-120N/AN/AN/A
12/31/2023212-95132195N/A
9/30/202377633N/AN/AN/A
6/30/20231,347159513610N/A
3/31/20231,598208N/AN/AN/A
12/31/20221,852258375483N/A
9/30/20221,39474N/AN/AN/A
6/30/20229373222257N/A
3/31/202285453N/AN/AN/A
12/31/2021624192841N/A
9/30/2021614113N/AN/AN/A
6/30/2021999155296426N/A
3/31/202179754N/AN/AN/A
12/31/202065630295422N/A
9/30/2020564-21N/AN/AN/A
6/30/202062-105-57-50N/A
3/31/202058-106N/AN/AN/A
12/31/201959-99-38-30N/A
9/30/201962-76N/AN/AN/A
6/30/201965-72-38-34N/A
3/31/201967-66N/AN/AN/A
12/31/201870-64-21-15N/A
9/30/201875-95N/AN/AN/A
6/30/201879-83-45-40N/A
3/31/201888-48N/AN/AN/A
12/31/2017105-63N/A-57N/A
9/30/2017111-48N/AN/AN/A
6/30/2017113-64N/A-11N/A
3/31/2017104-103N/AN/AN/A
12/31/201687-86N/A-25N/A
9/30/201669-81N/AN/AN/A
6/30/201652-84N/A-90N/A
3/31/201639-72N/AN/AN/A
12/31/201534-54N/A-85N/A
9/30/20153-36N/AN/AN/A
6/30/201538-21N/A-19N/A
3/31/201556-43N/AN/AN/A
12/31/201470-75N/A-40N/A
9/30/2014111-85N/AN/AN/A
6/30/201492-84N/A-78N/A
3/31/201489-79N/AN/AN/A
12/31/201385-60N/A-42N/A

アナリストによる今後の成長予測

収入対貯蓄率: 8037の予測収益成長が 貯蓄率 ( 2.3% ) を上回っているかどうかを判断するにはデータが不十分です。

収益対市場: 8037の収益がHong Kong市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です

高成長収益: 8037の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。

収益対市場: 8037の収益がHong Kong市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

高い収益成長: 8037の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: 8037の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です


成長企業の発掘